Bg pattern

ANSATIPIN 150 mg HARD CAPSULES

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use ANSATIPIN 150 mg HARD CAPSULES

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the Patient

Ansatipin 150mg Hard Capsules

rifabutin

Read the package leaflet carefully before starting to take this medicine because it contains important information for you.

  • Keep this package leaflet, as you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this package leaflet. See section 4.

Contents of the Package Leaflet

  1. What is Ansatipin 150 mg and what is it used for
  2. What you need to know before taking Ansatipin 150 mg
  3. How to take Ansatipin 150 mg
  4. Possible side effects
  5. Storage of Ansatipin 150 mg
  6. Contents of the pack and other information

1. What is Ansatipin 150 mg and what is it used for

Ansatipin 150 mg is an antibiotic belonging to the group of rifamycins.

Antibiotics are used to treat bacterial infections and are not effective against viral infections such as the flu or the common cold.

It is essential to follow the instructions regarding dosage, administration interval, and treatment duration as indicated by your doctor.

Do not store or reuse this medicine. If you have any leftover antibiotic after completing treatment, return it to the pharmacy for proper disposal. Do not throw medicines down the drain or in the trash.

It is used in adults for the prevention of Mycobacterium avium-intracellulare (MAC)infections in patients with HIV (Human Immunodeficiency Virus) infection, when clinically necessary.

Ansatipin is also used in adults for the treatment of the following infections when other treatments are not suitable:

  • Treatment of symptomatic localized or disseminated infection caused by atypical mycobacteria (such as Mycobacterium aviumand other species) in patients with HIV infection.
  • Treatment of pulmonary tuberculosis (Mycobacterium tuberculosis) when treatment with rifampicin is not suitable due to the risk of pharmacological interactions or in cases of resistance to rifampicin and confirmed sensitivity to rifabutin.

For the treatment of atypical mycobacteria and pulmonary tuberculosis, Ansatipin will always be given in combination with other active anti-mycobacterial drugs.

Consult your doctor if you have any questions about how Ansatipin works or why it has been prescribed for you.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before taking Ansatipin 150 mg

Do not take Ansatipin 150mg

  • if you are allergic to rifabutin or other medicines of the same family (rifamycins) such as rifampicin, or to any of the other components of this medicine (listed in section 6).
  • if you are receiving treatment with medicines containing rilpivirine administered as a prolonged-release injectable suspension.

Warnings and Precautions

Consult your doctor or pharmacist before starting treatment if:

  • You have a severe kidney or liver disease, as your doctor may need to adjust the dose of Ansatipin.
  • You are taking medicines for HIV, as they may interact with Ansatipin (see section Other medicines and Ansatipin 150 mg).
  • You are taking oral contraceptives, as Ansatipin may reduce their contraceptive effectiveness.

Consult your doctor or pharmacist if during treatment:

  • You experience severe skin reactions such as inflammation of the skin and mucous membranes that can be very severe (Stevens-Johnson syndrome), skin inflammation with blisters (toxic epidermal necrolysis), or drug rash with eosinophilia and systemic symptoms (DRESS, which includes skin rash, lymph node inflammation, and elevated eosinophils and inflammation of internal organs [liver, lungs, heart, kidneys, and large intestine]). In these cases, you should immediately consult your doctor, who will decide whether to discontinue rifabutin administration.
  • You are diagnosed with active tuberculosis, as you will need to be given anti-tuberculosis drugs.
  • You develop eye inflammation (uveitis). You should consult with your ophthalmologist and your doctor to determine if the dose should be reduced or treatment with Ansatipin discontinued.
  • You experience diarrhea, abdominal pain, or fever during or after treatment, as these may be symptoms of a severe intestinal disease. Inform your doctor, who will decide whether to discontinue treatment with Ansatipin or apply another suitable therapeutic measure.

Ansatipin may cause a reddish-orange discoloration of urine, as well as skin or other body secretions. Contact lenses may be permanently stained.

Children and Adolescents

The safety and efficacy of Ansatipin in children have not been established.

Other medicines and Ansatipin 150mg

Inform your doctor or pharmacist if you are using, have recently used, or might use any other medicines.

It is possible that treatment with Ansatipin may require modification of the doses of other medicines that are associated with treatment or that you are taking habitually due to interactions between them (increase or decrease of the effect of the medicines).

Therefore, if you start treatment with Ansatipin, it may be necessary for your doctor to closely monitor you and/or adjust the doses of certain medicines you are taking, such as:

  • medicines to prevent blood clotting (warfarin)
  • medicines to treat pain (opioid analgesics such as codeine and morphine)
  • anti-inflammatory medicines (corticosteroids)
  • immunosuppressants used to prevent transplant rejection (cyclosporine, tacrolimus)
  • medicines to treat heart diseases (digoxin, quinidine, verapamil, beta-blockers disopyramide or mexiletine)
  • medicines to treat diabetes (oral hypoglycemics)
  • antiepileptics (phenytoin and other anticonvulsants)
  • anxiolytics or sedatives (diazepam and barbiturates)
  • medicines to reduce triglycerides in the blood (clofibrate)
  • antibiotics to treat bacterial infections (dapsone, sulfamethoxazole-trimethoprim, clarithromycin, and chloramphenicol)
  • antifungals to treat fungal infections (ketoconazole, fluconazole, voriconazole, posaconazole, and itraconazole)
  • antiretrovirals to treat HIV (delavirdine, didanosine, dolutegravir, doravirine, elvitegravir/cobicistat, etravirine, indinavir, saquinavir, rilpivirine [for oral use, e.g., tablets], ritonavir, zidovudine, nelfinavir, amprenavir, bictegravir, combinations of atazanavir, darunavir, fosamprenavir, tipranavir, and lopinavir with ritonavir)
  • medicines to treat hepatitis C (sofosbuvir)
  • antitubercular medicines to treat tuberculosis (bedaquiline, ethambutol, isoniazid, rifampicin, and p-aminosalicylic acid). If rifabutin and p-aminosalicylic acid are administered, they should be taken 12 hours apart, as the latter may alter the absorption of Ansatipin.
  • antacids. If you take them, you should do so 3 hours after taking Ansatipin
  • oral contraceptives, as rifabutin may reduce their contraceptive effectiveness (ethinylestradiol/norethisterone)

Pregnancy, Breastfeeding, and Fertility

Consult your doctor or pharmacist before using any medicine.

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor before using this medicine.

You should not use Ansatipin during pregnancy unless your doctor considers it necessary.

Consult your doctor if you use oral contraceptives, as Ansatipin may reduce their contraceptive effectiveness.

It is not known whether rifabutin is excreted in breast milk. If you are breastfeeding, consult your doctor to determine whether to interrupt breastfeeding or discontinue treatment with Ansatipin.

Driving and Using Machines

The influence of this medicine on the ability to drive or use machines is negligible or nonexistent.

Ansatipin 150mg Hard Capsules contain Sodium

This medicine contains less than 1 mmol of sodium (23 mg) per capsule; it is essentially "sodium-free".

3. How to take Ansatipin 150 mg

Follow exactly the administration instructions of this medicine as indicated by your doctor. If in doubt, consult your doctor again.

The recommended dose of Ansatipin is taken once a day at any time of the day, regardless of meals. In patients with nausea, vomiting, or other gastrointestinal problems, administration with food is recommended.

Adults

  • If you take Ansatipin as the only treatment:

Indication

Posology

Prevention of Mycobacterium avium-intracellulare (MAC)infection in patients with HIV infection

300 mg (2 capsules) per day.

  • If you take Ansatipin with other treatments:

Indication

Posology

Infections caused by atypical mycobacteria:

450-600 mg (3 to 4 capsules) per day.

Pulmonary tuberculosis

150-450 mg (1 to 3 capsules) per day.

Your doctor will decide the duration of treatment based on the response obtained.

In patients with liver or kidney disease, your doctor will assess whether to adjust the dose of Ansatipin.

If you take more Ansatipin 150mg than you should

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately, or call the Toxicological Information Service at 91 562 04 20, indicating the medicine and the amount ingested.

If you forget to take Ansatipin

Do not take a double dose to make up for forgotten doses.

If you stop treatment with Ansatipin

Do not stop treatment with Ansatipin before your doctor has indicated, as symptoms may worsen or reappear.

If you have any other questions about the use of this medicine, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Consult your doctor immediatelyif you experience any of the following side effects:

  • Severe allergic reactions (anaphylactic shock) (frequency not known)
  • Severe skin reactions (see Warnings and Precautions)(frequency not known)

The following are other side effects that may occur:

The side effects very common (at least 1 in 10 patients)are:

  • Decrease in white blood cells (leukopenia).

The side effects common (at least 1 in 100 patients)are:

  • Decrease in the number of red blood cells in the blood (anemia).
  • Rash.
  • Nausea.
  • Muscle pain (myalgia).
  • Fever.

The side effects uncommon (at least 1 in 1,000 patients)are:

  • Decrease in all blood cells (pancytopenia).
  • Decrease in granulocytes, a type of blood cell (granulocytopenia or agranulocytosis).
  • Decrease in neutrophils, a type of blood cell (neutropenia).
  • Decrease in lymphocytes, a type of blood cell (lymphopenia).
  • Decrease in platelets (thrombocytopenia).
  • Increase in eosinophils, a type of blood cell (eosinophilia).
  • Allergic reactions (hypersensitivity).
  • Narrowing of the airways that makes it difficult for air to pass to the lungs (bronchospasm).
  • Eye inflammation (uveitis).
  • Eye disorders (corneal deposits).
  • Vomiting.
  • Yellowing of the skin and mucous membranes (jaundice).
  • Increased liver enzymes.
  • Change in skin color.
  • Joint pain (arthralgia).

The side effects with frequency not knownare:

  • Skin reactions: drug reaction with eosinophilia and systemic symptoms (DRESS), toxic epidermal necrolysis (TEN), Stevens-Johnson syndrome (SJS), acute generalized exanthematous pustulosis (AGEP), erythema multiforme, exfoliative dermatitis, bullous dermatitis.
  • Clostridiodes difficilecolitis, a severe intestinal disease.
  • Change in urine color.

Reporting of side effects

If you experience any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this package leaflet. You can also report side effects directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Ansatipin

Store below 25°C.

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiration date stated on the carton after EXP. The expiration date is the last day of the month indicated.

Do not use this medicine if you notice that the carton is damaged or has been opened.

Medicines should not be disposed of via wastewater or household waste. Place the empty packaging and any unused medicinal products in the SIGRE collection point at your pharmacy. If in doubt, ask your pharmacist how to dispose of packaging and unused medicines. This will help protect the environment.

6. Contents of the pack and other information

Composition of Ansatipin

  • The active substance is rifabutin.
  • The other components (excipients) are: microcrystalline cellulose (E460i), sodium lauryl sulfate (E487), magnesium stearate (E470b), and colloidal silica. The components of the capsule are: gelatin, red iron oxide (E172), and titanium dioxide (E171).

Appearance of the product and contents of the pack

Ansatipin is presented as hard gelatin capsules, opaque, and reddish-brown in color, packaged in transparent PVC/Aluminum blisters. Each pack contains 30 hard capsules.

Marketing Authorization Holder and Manufacturer

Marketing Authorization Holder

Binesa 2002, S.L.

Avda. de Europa, 20-B

Parque Empresarial La Moraleja

28108 Alcobendas (Madrid), Spain

Local Representative

Pfizer, S.L.

Avda. de Europa, 20-B

Parque Empresarial La Moraleja

28108 Alcobendas (Madrid), Spain

Manufacturer

Pfizer Italia S.r.L.

Via del Commercio

63046, Marino del Tronto, Ascoli-Piceno, Italy.

Date of the last revision of this package leaflet:June 2024

Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/)

Online doctors for ANSATIPIN 150 mg HARD CAPSULES

Discuss questions about ANSATIPIN 150 mg HARD CAPSULES, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

0.0 (0)
Doctor

Hocine Lokchiri

General medicine 21 years exp.

Dr. Hocine Lokchiri is a French consultant with over 20 years of experience in General and Emergency Medicine. He works with adults and children, helping patients with urgent symptoms, infections, sudden health changes and everyday medical concerns that require timely evaluation. His background includes clinical practice in France, Switzerland and the United Arab Emirates, which allows him to navigate different healthcare systems and manage a wide range of conditions with confidence. Patients value his calm, structured approach, clear explanations and evidence-based decision-making.

Online consultations with Dr. Lokchiri are suitable for many situations when someone needs quick medical guidance, reassurance or a clear next step. Common reasons for booking include:

  • fever, chills, fatigue and viral symptoms
  • cough, sore throat, nasal congestion, breathing discomfort
  • bronchitis and mild asthma flare-ups
  • nausea, diarrhoea, abdominal pain, digestive infections
  • rashes, allergic reactions, redness, insect bites
  • muscle or joint pain, mild injuries, sprains
  • headache, dizziness, migraine symptoms
  • stress-related symptoms, sleep disturbances
  • questions about test results and treatment plans
  • management of chronic conditions in stable phases
Many patients reach out when symptoms appear suddenly and cause concern, when a child becomes unwell unexpectedly, when a rash changes or spreads, or when it’s unclear whether an in-person examination is necessary. His emergency medicine background is particularly valuable online, helping patients understand risk levels, identify warning signs and choose safe next steps.

Some situations are not suitable for online care. If a patient has loss of consciousness, severe chest pain, uncontrolled bleeding, seizures, major trauma or symptoms suggesting a stroke or heart attack, he will advise seeking immediate local emergency services. This improves safety and ensures patients receive the right level of care.

Dr. Lokchiri’s professional training includes:

  • Advanced Trauma Life Support (ATLS)
  • Basic and Advanced Cardiac Life Support (BLS/ACLS)
  • Pediatric Advanced Life Support (PALS)
  • Prehospital Trauma Life Support (PHTLS)
  • eFAST and critical care transthoracic echocardiography
  • aviation medicine
He is an active member of several professional organisations, including the French Society of Emergency Medicine (SFMU), the French Association for Emergency Physicians (AMUF) and the Swiss Society of Emergency and Rescue Medicine (SGNOR). In consultations, he works with clarity and precision, helping patients understand their symptoms, possible risks and the safest treatment options.
Camera Book a video appointment
€58
0.0 (6)
Doctor

Daniel Cichi

Family medicine 24 years exp.

Dr Daniel Cichi is a family medicine doctor with over 20 years of clinical experience. He provides online consultations for adults, supporting patients with acute symptoms, chronic conditions, and everyday health concerns that require timely medical guidance. His background includes work in emergency care, ambulance services, and family medicine, which allows him to assess symptoms quickly, identify warning signs, and help patients choose the safest next steps – whether that means home care, treatment adjustment, or in-person evaluation. Patients commonly consult Dr Daniel Cichi for: 

  • acute symptoms: fever, infections, flu-like illness, cough, sore throat, shortness of breath;
  • chest discomfort, palpitations, dizziness, fatigue, and blood pressure concerns;
  • digestive problems: abdominal pain, nausea, diarrhoea, constipation, reflux;
  • sexually transmitted infections, erectile dysfunction;
  • muscle, joint, and back pain, minor injuries, post-traumatic symptoms;
  • chronic conditions: hypertension, diabetes, high cholesterol, thyroid disorders, weight loss, hair loss;
  • review and interpretation of lab tests, imaging reports, and medical documents;
  • medication review and treatment adjustment;
  • medical advice while travelling or living abroad;
  • second opinions and guidance on whether in-person care is needed.

Dr Cichi’s consultations are structured and practical. He focuses on clear explanations, risk assessment, and actionable recommendations, helping patients understand their symptoms and make informed decisions about their health.

Camera Book a video appointment
€55
5.0 (32)
Doctor

Dmytro Horobets

Family medicine 7 years exp.

Dr. Dmytro Horobets is a licensed family medicine physician in Poland, specialising in endocrinology, diabetology, obesity management, gastroenterology, pediatrics, general surgery, and pain medicine. He offers online consultations for adults and children, providing personalised medical support for a wide range of acute and chronic health concerns.

Areas of expertise:

  • Endocrinology: diabetes type 1 and type 2, prediabetes, thyroid disorders, metabolic syndrome, hormonal imbalance.
  • Obesity medicine: structured weight management plans, nutritional counselling, obesity-related health risks.
  • Gastroenterology: acid reflux (GERD), gastritis, irritable bowel syndrome (IBS), liver and biliary conditions.
  • Pediatric care: infections, respiratory symptoms, digestive issues, growth and development monitoring.
  • General surgery support: pre- and post-surgical consultations, wound care, rehabilitation.
  • Pain management: chronic and acute pain, back pain, joint pain, post-traumatic pain syndromes.
  • Cardiovascular health: hypertension, cholesterol control, risk assessment for heart disease.
  • Preventive medicine: regular check-ups, health screenings, long-term management of chronic conditions.

Dr. Horobets combines evidence-based medicine with a patient-centred approach. He carefully evaluates each patient’s medical history and symptoms, offering clear explanations and structured treatment plans adapted to individual needs.

Whether you need help managing diabetes, tackling weight-related health issues, interpreting lab results, or receiving general family medicine support, Dr. Horobets provides professional online care tailored to your specific health goals.

Camera Book a video appointment
€60
5.0 (4)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques. For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance. Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults. In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions. Patients commonly seek his care for: 

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns

Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.

Camera Book a video appointment
€80
5.0 (144)
Doctor

Yevgen Yakovenko

General surgery 12 years exp.

Dr. Yevgen Yakovenko is a licensed surgeon and general practitioner in Spain and Germany. He specialises in general, paediatric, and oncological surgery, internal medicine, and pain management. He offers online consultations for adults and children, combining surgical precision with therapeutic support. Dr Yakovenko works with patients across different countries and provides care in Ukrainian, Russian, English, and Spanish.

Areas of medical expertise:

  • Acute and chronic pain: headaches, muscle and joint pain, back pain, abdominal pain, postoperative pain. Identifying the cause, selecting treatment, and creating a care plan.
  • Internal medicine: heart, lungs, gastrointestinal tract, urinary system. Management of chronic conditions, symptom control, second opinions.
  • Pre- and postoperative care: risk assessment, decision-making support, follow-up after surgery, rehabilitation strategies.
  • General and paediatric surgery: hernias, appendicitis, congenital conditions, both planned and urgent surgeries.
  • Injuries and trauma: bruises, fractures, sprains, soft tissue damage, wound care, dressing, referral when in-person care is required.
  • Oncological surgery: diagnosis review, treatment planning, and long-term follow-up.
  • Obesity treatment and weight management: a medical approach to weight loss, including assessment of underlying causes, evaluation of comorbidities, development of a personalised plan (nutrition, physical activity, pharmacotherapy if needed), and ongoing progress monitoring.
  • Imaging interpretation: analysis of ultrasound, CT, MRI, and X-ray results, surgical planning based on imaging data.
  • Second opinions and medical navigation: clarifying diagnoses, reviewing current treatment plans, helping patients choose the best course of action.

Experience and qualifications:

  • 12+ years of clinical experience in university hospitals in Germany and Spain.
  • International education: Ukraine – Germany – Spain.
  • Member of the German Society of Surgeons (BDC).
  • Certified in radiological diagnostics and robotic surgery.
  • Active participant in international medical conferences and research.

Dr Yakovenko explains complex topics in a clear, accessible way. He works collaboratively with patients to analyse health issues and make evidence-based decisions. His approach is grounded in clinical excellence, scientific accuracy, and respect for each individual.

If you are unsure about a diagnosis, preparing for surgery, or want to discuss your test results – Dr Yakovenko will help you evaluate your options and move forward with confidence.

Camera Book a video appointment
€50

Frequently Asked Questions

Is a prescription required for ANSATIPIN 150 mg HARD CAPSULES?
ANSATIPIN 150 mg HARD CAPSULES requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in ANSATIPIN 150 mg HARD CAPSULES?
The active ingredient in ANSATIPIN 150 mg HARD CAPSULES is rifabutin. This information helps identify medicines with the same composition but different brand names.
How much does ANSATIPIN 150 mg HARD CAPSULES cost in pharmacies?
The average pharmacy price for ANSATIPIN 150 mg HARD CAPSULES is around 98.29 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures ANSATIPIN 150 mg HARD CAPSULES?
ANSATIPIN 150 mg HARD CAPSULES is manufactured by Binesa 2002 S.L.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of ANSATIPIN 150 mg HARD CAPSULES online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether ANSATIPIN 150 mg HARD CAPSULES is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to ANSATIPIN 150 mg HARD CAPSULES?
Other medicines with the same active substance (rifabutin) include RIFALDIN 20 mg/ml ORAL SUSPENSION, RIFALDIN 300 mg CAPSULES, RIFALDIN 600 mg POWDER AND SOLVENT FOR SOLUTION FOR INFUSION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media